Outcome parameters at univariable analysis.
bile fistula, urosepsis
ADVERSE EVENTS, SECONDARY, INTRA-ABDOMINAL ABSCESSES, UROSEPSIS
AST: aspartate aminotransaminase, ALT: alanine aminotransaminase, tBil: total bilirubin, SAE: serious adverse events.* Data are presented as the % of the total number or mean [standard deviation].** A p-value less than 0.05 was considered to be statistically significant.The secondary outcomes were not significantly different between the two groups (tBil: sevoflurane 1.24 [0.53] mg/dL versus propofol 1.16 [0.41] mg/dL; p = 0.55. SAE: sevoflurane 10.7% versus propofol 7.1%; p = 1). SAE included four patients who developed bile fistula or intra-abdominal abscesses needing drainage (two patients per group) and one with urosepsis (in the sevoflurane group).Postoperative peak values of AST and ALT were significantly affected by the choice of anesthetic agent (propofol p = 0.008 and 0.007, respectively) and TIT (p = 0.001 and p = 0.0004, respectively, 